Summary: Parkinson’s disease affects more than 10 million people globally, standing second only to dementia among devastating neurological disorders. The disease is pathologically characterized by the progressive destruction of dopamine-producing…
Category: Featured
Hearing Aids Linked to 23% Lower Dementia Risk in Epilepsy
Summary: Hearing loss has long been recognized as a leading modifiable risk factor for dementia, yet the real-world efficacy of hearing aids in preventing cognitive decline remains a subject of…
Long-Term Iron Accumulation Strips Neurons of Disease Resilience
Summary: Neurodegenerative conditions like Alzheimer’s and Parkinson’s diseases afflict tens of millions of people worldwide, driven by a complex web of cellular vulnerabilities that scientists are actively racing to untangle.…
Personalized fMRI Scans Supercharge TMS Depression Treatment
Summary: A new randomized clinical trial suggests that using personalized brain imaging to guide transcranial magnetic stimulation (TMS) may significantly improve outcomes for people with treatment-resistant depression. Investigators demonstrated that…
GABA Immune Pathway Drives Female Brain Cancer Growth
Summary: Glioblastoma, the most common and lethal form of brain cancer, exhibits striking differences between men and women in its incidence, treatment responses, and survival rates. A groundbreaking study has…
